Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.
Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE. Buchbinder D, et al. Among authors: daly a. Bone Marrow Transplant. 2018 May;53(5):535-555. doi: 10.1038/s41409-017-0055-7. Epub 2018 Jan 17. Bone Marrow Transplant. 2018. PMID: 29343837 Free PMC article. Review.
Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG.
El Kourashy S, Williamson T, Chaudhry MA, Savoie ML, Turner AR, Larratt L, Storek J, Bahlis NJ, Brown CB, Yang M, Quinlan D, Geddes M, Zacarias N, Daly A, Duggan P, Stewart DA, Russell JA. El Kourashy S, et al. Among authors: daly a. Bone Marrow Transplant. 2011 Aug;46(8):1077-83. doi: 10.1038/bmt.2010.257. Epub 2010 Nov 8. Bone Marrow Transplant. 2011. PMID: 21057555
High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts.
Hoegh-Petersen M, Goodyear D, Geddes MN, Liu S, Ugarte-Torres A, Liu Y, Walker JT, Fonseca K, Daly A, Duggan P, Stewart D, Russell JA, Storek J. Hoegh-Petersen M, et al. Among authors: daly a. Bone Marrow Transplant. 2011 Aug;46(8):1104-12. doi: 10.1038/bmt.2010.272. Epub 2010 Nov 8. Bone Marrow Transplant. 2011. PMID: 21057556
IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD.
Pratt LM, Liu Y, Ugarte-Torres A, Hoegh-Petersen M, Podgorny PJ, Lyon AW, Williamson TS, Khan FM, Chaudhry MA, Daly A, Stewart DA, Russell JA, Grigg A, Ritchie D, Storek J. Pratt LM, et al. Among authors: daly a. Bone Marrow Transplant. 2013 May;48(5):722-8. doi: 10.1038/bmt.2012.210. Epub 2012 Nov 19. Bone Marrow Transplant. 2013. PMID: 23165502
Prognosis of grade 3-4 acute GVHD continues to be dismal.
Jamani K, Russell JA, Daly A, Stewart D, Savoie L, Duggan P, Storek J. Jamani K, et al. Among authors: daly a. Bone Marrow Transplant. 2013 Oct;48(10):1359-61. doi: 10.1038/bmt.2013.59. Epub 2013 Apr 22. Bone Marrow Transplant. 2013. PMID: 23604011 No abstract available.
Fludarabine metabolite level on day zero does not affect outcomes of hematopoietic cell transplantation in patients with normal renal function.
Griffiths CD, Ng ES, Kangarloo SB, Williamson TS, Chaudhry MA, Booker R, Duggan P, Yue P, Savoie L, Brown C, Cox-Kennett N, Russell JA, Daly A, Storek J. Griffiths CD, et al. Among authors: daly a. Bone Marrow Transplant. 2014 Apr;49(4):589-91. doi: 10.1038/bmt.2013.234. Epub 2014 Jan 27. Bone Marrow Transplant. 2014. PMID: 24464143 No abstract available.
Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with thymoglobulin GVHD prophylaxis.
Lim AB, Storek J, Beligaswatte A, Collins M, Tacey M, Williamson T, Mason K, Li E, Chaudhry MA, Russell JA, Daly A, Szer J, Lewis I, Ritchie D. Lim AB, et al. Among authors: daly a. Bone Marrow Transplant. 2015 Apr;50(4):566-72. doi: 10.1038/bmt.2014.313. Epub 2015 Feb 2. Bone Marrow Transplant. 2015. PMID: 25642763 Clinical Trial.
1,168 results